×
About 4,455 results

ALLMedicine™ Myasthenia Gravis Center

Research & Reviews  1,617 results

Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes.
https://doi.org/10.4049/jimmunol.2100225
Journal of Immunology (Baltimore, Md. : 1950); Mandel-Brehm C, Fichtner ML et. al.

Sep 22nd, 2021 - Elevated N-linked glycosylation of IgG V regions (IgG-VN-Glyc) is an emerging molecular phenotype associated with autoimmune disorders. To test the broader specificity of elevated IgG-VN-Glyc, we studied patients with distinct subtypes of myasthen...

How does Rituximab fit in the Treatment Algorithm of Myasthenia Gravis?
https://doi.org/10.1002/mus.27421
Muscle & Nerve; Kushlaf H, Li Y

Sep 22nd, 2021 - How does Rituximab fit in the Treatment Algorithm of Myasthenia Gravis?|2021|Kushlaf H,Li Y,|

Therapeutic Approaches for the Management of Autoimmune Disorders via Gene Therapy: Pro...
https://doi.org/10.2174/1566523221666210916113609
Current Gene Therapy; Sindhu RK, Madaan P et. al.

Sep 18th, 2021 - Autoimmune diseases are the diseases that result due to the overactive immune response, and comprise systemic autoimmune diseases like rheumatoid arthritis (RA), sjӧgren's syndrome (SS), and organ-specific autoimmune diseases like type-1 diabetes ...

The impact of myasthenia gravis on lower urinary tract functions.
https://doi.org/10.1111/ijcp.14873
International Journal of Clinical Practice; Akan O, Polat EC et. al.

Sep 16th, 2021 - To assess the functions of the lower urinary tract (LUT) in patients with myasthenia gravis (MG). A total of 36 patients (18 males and 18 females) with MG and 29 healthy controls were enrolled. Participants completed a 3-day voiding diary and resp...

Neurological disorders associated with immune checkpoint inhibitors: an association wit...
https://doi.org/10.1007/s00262-021-03053-9 10.1200/jco.2017.77.6385 10.1056/NEJMra1703481 10.1016/j.jaut.2019.03.005 10.1136/jnnp-2020-323055 10.1038/s41591-019-0523-2 10.1155/2018/2548528 10.1136/jnnp-2020-323212 10.1001/jamaneurol.2016.1399 10.1212/NXI.0000000000000604 10.1038/s41571-019-0194-4 10.1111/fcp.12349 10.1007/s00415-020-10213-x 10.1001/jamaneurol.2017.1912 10.1212/WNL.0000000000008091 10.1212/WNL.0000000000011340 10.1136/jnnp-2017-316510 10.1093/jjco/hyw090 10.1056/NEJMc1515584 10.1186/s40425-019-0774-y 10.1212/wnl.0000000000004359 10.1212/WNL.0000000000007235 10.2169/internalmedicine.9153-17 10.1212/wnl.0000000000006124 10.1002/art.41604 10.1007/s11926-019-0811-3 10.1186/s40425-019-0736-4 10.1097/CJI.0000000000000196 10.1002/ana.25708 10.1056/NEJMoa1609214 10.1161/circulationaha.118.035898 10.1038/s41598-019-41730-z 10.1093/annonc/mdw655 10.1186/s40425-016-0139-8 10.1002/acn3.654 10.1186/s40425-019-0617-x 10.1093/annonc/mdw558 10.1016/j.ejca.2016.12.001 10.1002/acn3.51213 10.1001/jamaoncol.2017.2925 10.1001/jamaoncol.2019.1022 10.1093/annonc/mdw443
Cancer Immunology, Immunotherapy : CII; Seki M, Kitano S et. al.

Sep 14th, 2021 - Among diverse neurological immune-related adverse events (irAEs), autoimmune encephalitis, aseptic meningitis, Guillain-Barré syndrome (GBS), myasthenia gravis (MG), and myositis are particularly important. The clinical presentation may be differe...

see more →

Guidelines  4 results

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic synd...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105910
Journal of the Neurological Sciences; , Jacob S et. al.

Apr 5th, 2020 - Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.|2020| ,Jacob S,Muppidi S,Guidon A,Guptill J,|complications,drug therapy,epidemiology,therapeutic use,therapeutic use,t...

The Association of British Neurologists' myasthenia gravis guidelines.
https://doi.org/10.1111/nyas.13503
Annals of the New York Academy of Sciences; Sussman J, Farrugia ME et. al.

Nov 10th, 2017 - Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction for which many therapies were developed before the era of evidence-based medicine. Despite the basic principles of treatment being well known, patients continue to recei...

Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critical...
https://doi.org/10.1097/CCM.0000000000002027
Critical Care Medicine; Murray MJ, DeBlock H et. al.

Oct 19th, 2016 - To update the 2002 version of "Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient." A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of n...

International consensus guidance for management of myasthenia gravis: Executive summary.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977114
Neurology Sanders DB, Wolfe GI et. al.

Jul 1st, 2016 - To develop formal consensus-based guidance for the management of myasthenia gravis (MG). In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international expe...

see more →

Drugs  50 results see all →

News  108 results

Fast Five Quiz: Refresh and Test Your Knowledge of Myasthenia Gravis
https://www.medscape.com/viewarticle/899540

Jul 6th, 2021 - Myasthenia gravis (MG) is a relatively rare autoimmune disorder in which antibodies form against nicotinic acetylcholine (ACh) postsynaptic receptors at the neuromuscular junction of the skeletal muscles. It is a type II hypersensitivity immune re...

Potential First-in-Class, Targeted Therapy for Myasthenia Gravis
https://www.medscape.com/viewarticle/953330

Jun 17th, 2021 - Efgartigimod (argenx) is an effective and well-tolerated therapy for patients with generalized myasthenia gravis (gMG), new research suggests. Results from the phase 3, randomized, placebo-controlled ADAPT trial showed that reduction in disease bu...

New Steroid Dosing Regimen for Myasthenia Gravis
https://www.medscape.com/viewarticle/945898

Feb 16th, 2021 - The findings of a new randomized trial support the rapid tapering of prednisone in patients with generalized myasthenia gravis requiring combined corticosteroid and azathioprine therapy. The trial showed that the conventional slow tapering regimen...

Ocular Side Effects Possible With Checkpoint Inhibitors
https://www.medscape.com/viewarticle/941652

Nov 27th, 2020 - NEW YORK (Reuters Health) - People who use immune-checkpoint inhibitors have an increased risk of noninfectious uveitis and myasthenia gravis, according to a database study. Several case series have reported ocular side effects of checkpoint inhib...

COVID-19 Linked to Development of Myasthenia Gravis
https://www.medscape.com/viewarticle/935985

Aug 19th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Myasthenia gravis should be added to the growing list of potential neurological sequelae associated with COVID-19, new research suggests. Clinicia...

see more →

Patient Education  3 results see all →